Father's Day Sale — Get 40% off Vantage for yourself or as a gift

Published 5 years ago • loading... • Updated 5 years ago

FDA approves IDE for Juvene IOL

Summary by Healio

LensGen has received approval for an investigational device exemption from the FDA, paving the way for a pivotal study of the Juvene IOL, according to a company press release. "We are proud to achieve this significant milestone for the company, which allows us to move forward with the IDE pivotal trial with the ultimate goal of seeking premarket approval in the largest eye care market in the

1 Articles

1 Articles

FDA approves IDE for Juvene IOL

LensGen has received approval for an investigational device exemption from the FDA, paving the way for a pivotal study of the Juvene IOL, according to a company press release. "We are proud to achieve this significant milestone for the company, which allows us to move forward with the IDE pivotal trial with the ultimate goal of seeking premarket approval in the largest eye care market in the

5 years ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated5 years agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Healio broke the news 5 years ago on Monday, November 29, 2021.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics